Search by Drug Name or NDC
NDC 00283-0808-02 CEO-TWO 927; 618 mg/3.7g; mg/3.7g Details
CEO-TWO 927; 618 mg/3.7g; mg/3.7g
CEO-TWO is a RECTAL SUPPOSITORY in the HUMAN OTC DRUG category. It is labeled and distributed by Beutlich Pharmaceuticals, LLC. The primary component is POTASSIUM BITARTRATE; SODIUM BICARBONATE.
Product Information
| NDC | 00283-0808 |
|---|---|
| Product ID | 0283-0808_087c799b-bb16-48ad-e063-6394a90a294c |
| Associated GPIs | 46600050005200 |
| GCN Sequence Number | 003073 |
| GCN Sequence Number Description | potassium bitart/sodium bicarb SUPP.RECT 0.9G-0.6G RECTAL |
| HIC3 | Q3S |
| HIC3 Description | LAXATIVES, LOCAL/RECTAL |
| GCN | 66690 |
| HICL Sequence Number | 001352 |
| HICL Sequence Number Description | POTASSIUM BITARTRATE/SODIUM BICARBONATE |
| Brand/Generic | Brand |
| Proprietary Name | CEO-TWO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Laxative |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SUPPOSITORY |
| Route | RECTAL |
| Active Ingredient Strength | 927; 618 |
| Active Ingredient Units | mg/3.7g; mg/3.7g |
| Substance Name | POTASSIUM BITARTRATE; SODIUM BICARBONATE |
| Labeler Name | Beutlich Pharmaceuticals, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | n/a |
Package
NDC 00283-0808-02 (00283080802)
| NDC Package Code | 0283-0808-02 |
|---|---|
| Billing NDC | 00283080802 |
| Package | 2 DOSE PACK in 1 BOX (0283-0808-02) / 5.7 g in 1 DOSE PACK (0283-0808-01) |
| Marketing Start Date | 2023-10-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |